-
Capsazepine for TRPV1 Ion Channel Research
2026-08-25
Capsazepine is a practical mechanistic probe for separating TRPV1-driven nociception from broader inflammatory and affective pain pathways. This workflow shows how to apply it in calcium imaging, sensory-neuron assays, behavioral models, TRPM8 experiments, and apoptosis studies while controlling for solubility and off-target effects.
-
(R)-MG132 for Proteasome Control
2026-08-24
(R)-MG132 is a functionally inactive MG-132 enantiomer designed to separate proteasome-dependent effects from solvent, peptide-aldehyde, and nonspecific stress responses. Used alongside active MG-132, it adds a rigorous control layer to HNRNPU lactylation, PHGDH regulation, and cancer-metabolism assays.
-
Computational Hapten Design for Dual Toxin Detection
2026-08-24
This 2026 study combines molecular similarity analysis, quantum-chemical calculations, and monoclonal antibody development to create a fluorescent immunochromatographic assay for simultaneous detection of amatoxins and phallotoxins in mushrooms. The resulting assay achieved low nanogram-per-milliliter antibody sensitivities and low microgram-per-kilogram detection limits in mushroom matrices, providing a practical complement to laboratory instrumental analysis.
-
3D Tumor Spheroids for Glioblastoma Stemness
2026-08-23
Chen et al. present a streamlined 96-well 3D-tumor spheroid assay for functional assessment of stem-like phenotypes in glioblastoma cell lines. By replacing a slower two-round sphere-forming workflow with a compact seeding, centrifugation, and imaging procedure, the method supports reproducible mechanistic studies and higher-throughput screening while still requiring orthogonal validation.
-
Neomycin sulfate for RNA, DNA, and Channel Assays
2026-08-22
Neomycin sulfate is an aminoglycoside antibiotic repurposed as a mechanistic probe for structured RNA, DNA triplexes, HIV-1 TAR recognition, and ryanodine receptor conductance. This workflow-focused guide explains how to choose concentrations, separate binding from catalysis, and control matrix effects without confusing exploratory antibiotic exposure with disease-treatment evidence.
-
Xenopus laevis Pluripotency Network Rewiring
2026-08-21
The reference study shows that hybridization rewired early pluripotency regulation in allotetraploid Xenopus laevis through asymmetric activation of homeologous genes and divergent enhancer architectures. Despite this regulatory divergence, combined L- and S-subgenome expression preserves the dosage of core embryonic transcriptional programs, revealing how selection can stabilize development after genome duplication.
-
From Kinases to Condensates: A Translational Playbook
2026-08-21
A mechanistic and strategic framework for using the CK2 and ERK8 inhibitor as a controlled perturbation tool in kinase signaling, protein interaction, and phase-separation research—without overstating an unproven antiviral mechanism.
-
MG-132 (Z-LLL-al) for Proteasome Assays
2026-08-20
MG-132 (Z-LLL-al) provides a cell-permeable way to perturb proteasome-dependent protein turnover while tracking apoptosis, cell cycle arrest, oxidative stress, and mitochondrial quality control. Its most useful application is comparative mechanism testing: pair proteasome inhibition with ubiquitination, LC3, ROS, viability, and mitochondrial readouts rather than treating it as a pathway-specific mitophagy reagent.
-
MCL1 Resistance Biology Meets L1023 Screening
2026-08-20
MCL1-mediated apoptosis resistance is a compelling test case for translating mechanistic oncology findings into pathway-aware screening. This article shows how the DiscoveryProbe™ Anti-cancer Compound Library (SKU: L1023) can support structured comparison of apoptosis, kinase, proteostasis, and mTOR-linked dependencies without mistaking a phenotypic hit for a validated target mechanism.
-
Berbamine Hydrochloride as a Ferroptosis Probe
2026-08-19
Explore how Berbamine hydrochloride can be used as an NF-κB activity inhibitor and experimental perturbation tool in cancer research. This article translates the METTL16-SENP3-LTF ferroptosis findings into practical assay strategies without overclaiming direct pathway targeting.
-
Triptolide (PG490): Phase-Aware Assay Design
2026-08-19
Triptolide (PG490) is a potent transcriptional inhibitor with applications in cancer research, immunology, and inflammatory disease models. This guide introduces a phase-aware strategy that connects its RNAPII-centered activity with cell-cycle transcription condensate biology to improve assay timing, controls, and interpretation.
-
Microfluidic Peptide–RNA Complexes for Lung Delivery
2026-08-18
This 2025 study shows that microfluidic mixing can reproducibly prepare LAH4-L1 and PEG12KL4 peptide complexes with siRNA or mRNA for nebulized pulmonary delivery. The complexes generated inhalable aerosols and retained RNA binding and in vitro transfection performance after vibrating-mesh nebulization, supporting further development of peptide-based mRNA delivery system research.
-
EPZ5676: A Practical DOT1L Inhibitor Workflow
2026-08-18
EPZ5676 combines sub-nanomolar biochemical potency with strong selectivity, making it a useful reference compound for H3K79 methylation inhibition and MLL-rearranged leukemia research. This guide connects biochemical testing, cellular target engagement, chromatin assays, and troubleshooting while clarifying how a rectal organoid study can inform—not replace—DOT1L-specific experiments.
-
Aconitase Activity Colorimetric Assay Kit Guide
2026-08-17
The Aconitase Activity Colorimetric Assay Kit provides a rapid biochemical readout of citrate-to-isocitrate conversion through color development at 450 nm. K2226 is useful for TCA cycle enzyme assay workflows and oxidative damage measurement, but its signal should not be interpreted as a direct measurement of reactive oxygen species or aconitase abundance.
-
α-Amanitin: From RNAP II Probe to Translational Insight
2026-08-17
α-Amanitin is more than a potent RNA polymerase II inhibitor: it is a causal perturbation tool for connecting transcriptional control to phenotype. This thought-leadership guide integrates mechanism, assay design, product strategy, and the emerging toxicology relevance of α-amanitin, including insights from CRISPR screening and STT3B biology.